title: Pulmonary arterial hypertension: future directions: report of a National Heart, Lung and Blood Institute/Office of Rare Diseases workshop.
authors.affiliation: Departments of Medicine, Nashville VA Medical Center (GRECC), and Vanderbilt University, Nashville, Tenn, USA.
authors.forename: John H
authors.initials: JH
authors.lastname: Newman
authors.forename: Barry L
authors.initials: BL
authors.lastname: Fanburg
authors.forename: Stephen L
authors.initials: SL
authors.lastname: Archer
authors.forename: David B
authors.initials: DB
authors.lastname: Badesch
authors.forename: Robyn J
authors.initials: RJ
authors.lastname: Barst
authors.forename: Joe G N
authors.initials: JG
authors.lastname: Garcia
authors.forename: Peter N
authors.initials: PN
authors.lastname: Kao
authors.forename: James A
authors.initials: JA
authors.lastname: Knowles
authors.forename: James E
authors.initials: JE
authors.lastname: Loyd
authors.forename: Michael D
authors.initials: MD
authors.lastname: McGoon
authors.forename: Jane H
authors.initials: JH
authors.lastname: Morse
authors.forename: William C
authors.initials: WC
authors.lastname: Nichols
authors.forename: Marlene
authors.initials: M
authors.lastname: Rabinovitch
authors.forename: David M
authors.initials: DM
authors.lastname: Rodman
authors.forename: Troy
authors.initials: T
authors.lastname: Stevens
authors.forename: Rubin M
authors.initials: RM
authors.lastname: Tuder
authors.forename: Norbert F
authors.initials: NF
authors.lastname: Voelkel
authors.forename: Dorothy B
authors.initials: DB
authors.lastname: Gail
mesh_terms: D000328:Adult; D000818:Animals; D001120:Arginine / Q000627:therapeutic use; D052006:Bone Morphogenetic Protein Receptors, Type II; D004791:Enzyme Inhibitors / Q000494:pharmacology / Q000627:therapeutic use; D005260:Female; D005544:Forecasting; D020022:Genetic Predisposition to Disease; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000627:therapeutic use; D006976:Hypertension, Pulmonary / Q000150:complications / Q000235:genetics / Q000401:mortality / Q000628:therapy; D008297:Male; D008954:Models, Biological; D010196:Pancreatic Elastase / Q000037:antagonists & inhibitors; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use; D015221:Potassium Channels / Q000502:physiology; D017346:Protein Serine-Threonine Kinases / Q000235:genetics; D051381:Rats; D012106:Research / Q000639:trends; D015398:Signal Transduction
chemical_list: D004791:Enzyme Inhibitors; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D010975:Platelet Aggregation Inhibitors; D015221:Potassium Channels; D001120:Arginine; D017346:Protein Serine-Threonine Kinases; C498218:BMPR2 protein, human; C498220:Bmpr2 protein, rat; D052006:Bone Morphogenetic Protein Receptors, Type II; D010196:Pancreatic Elastase